Use of antidiabetic medications and risk of chronic obstructive pulmonary disease exacerbation requiring hospitalization: a disease risk score-matched nested case–control study

BACKGROUND: Exacerbation of chronic obstructive pulmonary disease (COPD) severely impacts the quality of life and causes high mortality and morbidity. COPD is involved with systemic and pulmonary inflammation, which may be attenuated with antidiabetic agents exerting anti-inflammatory effects. Real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng-Ting, Lai, Jyun-Heng, Huang, Ya-Ling, Kuo, Feng-Chih, Wang, Yun-Han, Tsai, Chen-Liang, Tu, Min-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709288/
https://www.ncbi.nlm.nih.gov/pubmed/33267895
http://dx.doi.org/10.1186/s12931-020-01547-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709288/
https://www.ncbi.nlm.nih.gov/pubmed/33267895
http://dx.doi.org/10.1186/s12931-020-01547-1

Ejemplares similares